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http://dx.doi.org/10.1016/j.pedneo.2Influenza virus infection is extremely common and raises global concern due to the increasing
prevalence of pandemic H1N1 infection. Influenza may occasionally be associated with neuro-
logic complications and, also, rarely with gastrointestinal complications. Here, we report a rare
case complicated with appendicitis, duodenum perforation, and transient delirious behavior
after influenza A viral infection in a pediatric patient aged 14 years. The transient delirious
behavior could be attributed to postinfectious encephalopathy. The perforated peptic ulcer
could have resulted from influenza infection, could have been an adverse event related to
oseltamivir administration, or could have been a complication of preceding gastroenteritis.
Our case highlights the importance of pediatric healthcare workers to be aware of possible
complications arising from both influenza infection and oseltamivir therapy, even though some
of these complications may be relatively rare.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Seasonal influenza infection is extremely common each
winter, but the gravity of infection has increased since thet of Critical Care Medicine,
angtai Road, Pingjen City,
m.tw (C.-P. Wu).
an Pediatric Association. Publish
013.01.005advent of the pandemic influenza A H1N1 infection, which
has now become a global concern.1,2 Although most sea-
sonal and H1N1 influenza infections are self-limiting, severe
complications may develop. Pulmonary complications are
most common and include primary influenza pneumonia
and secondary bacterial pneumonia.3 Neurological compli-
cations, including encephalitis, encephalopathy Reye syn-
drome, GuillaineBarre´ syndrome, transverse myelitis,
acute disseminated encephalomyelitis (ADEM), and post-
infectious encephalopathy, can also occur; neurologicaled by Elsevier Taiwan LLC. All rights reserved.
282 C.-W. Hsueh et alcomplications are more common in pediatric patients that
in adult patients.4e6 Gastrointestinal complications are
rare and mostly limited to symptoms such as diarrhea.3,7 In
pediatric patients, pulmonary complications tend to be the
most common complication; for example, one study in Italy
noted that of 40 children with H1N1 complications, pul-
monary disease was observed in 32 and neurological disor-
ders in three.8,9 In addition, a study of 532 children with
H1N1 influenza infection in Turkey reported hospitalization
of 66 for respiratory failure, of six for neurological deteri-
oration, and of five for gastrointestinal symptoms.10
Vaccination is the most effective means of preventing
influenza-associated morbidity and mortality.11 Once the
infection has occurred, prompt initiation of antiviral medi-
cations may reduce the complications associated with acute
influenza. Neuraminidase inhibitors such as oseltamivir and
zanamivir are the most commonly prescribed antivirals for
treating influenza infection, and they have been reported to
reduce the incidence of complications associated with this
infection.3 In Taiwan, oseltamivir may be given to patients
at high risk for complications. However, vaccination and
administration of antiviral medications can result in further
complications. For example, vaccination has been observed
to result in GuillianeBarre´ syndrome, although very rarely;
also, abnormal behavior, nausea, headache, epigastric pain,
and allergic reactions have all been reported in association
with oseltamivir and zanamivir therapy, but these symptoms
are mostly mild and relatively rare.3,12
Here, we report the case of a pediatric patient with
influenza A infection who developed postinfectious en-
cephalopathy complicated by a perforated peptic ulcer.Figure 1 A chest and abdominal X-ray showing free air un-
derneath the diaphragm (black arrowhead).2. Case Report
A previously healthy, 14-year-old female was admitted to
our hospital with a 5-day history of abdominal pain, diar-
rhea, and loss of appetite. Vomiting and fever had also
been present for 2 days. The patient had no past history
of peptic ulcers, and she had never undergone any
panendoscopy.
On admission, the patient’s vital signs were normal and
physical examination was unremarkable except for a soft
and distended abdomen with diffuse mild tenderness.
Abdominal X-ray showed prominent large bowel gas but
no fecalis. Abdominal sonography identified colonic dila-
tation with stasis compatible with severe acute gastro-
enteritis; there was no evidence of appendicitis. Initial
laboratory findings were as follows: hemoglobin level,
16.2 g/dL; hematocrit, 44.9%; white blood cell count,
13.6  109/L, with 80% neutrophils and 0% band cells; and
platelet count, 195  109/L. The patient’s C-reactive pro-
tein level was high (250 mg/dL), and serum glucose level
and liver function tests were within normal limits. Her stool
was negative for occult blood, parasite ova, and rota virus
antigen. A stool culture showed growth of normal intestinal
flora. The patient was subsequently treated with an empiric
antibiotic (ceftriaxone), and intravenous fluids were
administered due to her nil-by-mouth status.
The patient’s fever subsided and diarrhea improved, but
on the 3rd day after admission, she developed high fever,
malaise, and myalgia. A rapid influenza test was performedand the result was positive for influenza A (serotyping of
the virus was not performed). Subsequently, the patient
was prescribed a 5-day course of oseltamivir. Her condition
improved as fever subsided and oral intake of food was
initiated. However, diffuse abdominal pain, vomiting, and
fever occurred 3 days after initiation of oseltamivir ther-
apy. A chest and abdominal X-ray showed free air under-
neath the diaphragm (Figure 1). Acute abdomen and viscus
perforation were thus suspected, and the patient under-
went an emergency exploratory laparotomy. Intraoperative
findings included peritonitis due to a perforated duodenal
ulcer about 2 cm in diameter and appendicitis. The perfo-
rated duodenal ulcer was closed, and an appendectomy
was performed. The patient’s fever persisted and turbid
pus was discharged via a JacksonePratt drainage system.
Antrectomy with Roux-en-Y gastrojejunostomy was per-
formed 6 days later, as the previously perforated duodenal
ulcer had not healed and bile leakage had occurred.
Three weeks after admission, the patient developed
symptoms of an altered state of consciousness with nys-
tagmus on right gaze, disorientation and moaning, and
talking to herself. A lumbar puncture was performed, and
analysis of the cerebrospinal fluid (CSF) showed a white
blood cell count of 0/L and a red blood cell count of
0.3  109/L (possibly due to trauma from the lumbar punc-
ture). The CSF glucose level was 3.5 mmol/L and the CSF
protein level 125 mg/dL. CSF virus, bacteria, and myco-
bacteria cultures were all negative. CSF polymerase chain
reactions for HSV-1 and HSV-2 were also negative. Magnetic
resonance imaging (MRI) scans of the brain revealed a few
small high-signal lesions in the periaqueduct gray matter,
bilateral thalamus, and posterior brain stem on T2- and
FLAIR-weighted images (Figure 2), which were suggestive of
postinfectious encephalopathy. Electroencephalography
Figure 2 T2-weighed brain MRI reveals some small high-
signal lesions in the periaqueduct gray matter, bilateral tha-
lamus (white arrowhead). MRIZ magnetic resonance imaging.
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leptiform discharge.
The patient was transferred to the pediatric intensive
care unit of another medical center where she was treated
with acyclovir, intravenous immunoglobulin, and cortico-
steroids due to suspected postinfectious encephalopathy.
An abdominal computed tomography scan revealed multi-
focal intra-abdominal abscesses. Antibiotic treatment was
continued. Gradually, the patient’s level of consciousness
improved, and she was discharged 2 months after hospi-
talization. After 4 months, the patient’s electro-
encephalogram was normal, and a panendoscopy showed
no sign of ulceration.3. Discussion
Severe complications of seasonal influenza or H1N1 influ-
enza infections include primary influenza pneumonia,
myocarditis, pericarditis, and invasive secondary bacterial
infections. Neurological complications, including seizures,
encephalitis, encephalopathy, Reye syndrome, Guil-
lianeBarre´ syndrome, and transverse myelitis, can also
occur occasionally,5,13,14 as can gastrointestinal complica-
tions, but these are rare. Postinfectious encephalopathy or
ADEM following influenza infection has also been reported
rarely.6,8,15e17
ADEM usually follows a viral infection or, less frequently,
vaccination.18 Measles, varicella, rubella, mumps, and
influenza viruses are most frequently associated with
ADEM.18,19 Neurological symptoms including impaired con-
sciousness and focal neurological signs usually develop
suddenly after a minor infection or vaccination, with a la-
tency period of 2e30 days.20 Our patient developed neu-
rologic symptoms 3 weeks after initial influenza A infection.
Her medical history, clinical presentation, and specific MRIfindings led to a presumptive diagnosis of postinfectious
encephalopathy.
In Taiwan, oseltamivir has been administered as a first-
line therapy for patients with a positive result for influenza
A or H1N1 influenza infection, and these patients are at
high risk of developing complications.9 The recommended
duration of the standard therapy is 5 days. Our patient was
given oseltamivir immediately after the result of a rapid
test for influenza A was positive. However, she developed
severe abdominal pain 3 days after taking oseltamivir.
Abdominal study showed a viscus perforation, and surgical
findings revealed a perforated peptic ulcer. This ulcer could
have resulted from direct influenza virus invasion, could
have been an adverse effect of oseltamivir therapy, or
could have been a complication arising from the preceding
gastroenteritis.
Our review of related literature has revealed no previous
reports of perforated peptic ulcer complicating influenza
infection or oseltamivir therapy. The incidence of
influenza-associated gastrointestinal symptoms including
nausea, vomiting, and diarrhea is uncommon.21e23 Howev-
er, there have been a few case reports concerning severe
gastrointestinal complications, including gastrointestinal
hemorrhage and hemorrhagic gastritis.7,24 Kendirli et al
reported the development of intestinal perforation in one
(1.2%) of 83 children with H1N1 infection admitted to their
pediatric intensive care unit.10 There has also been a case
report of acute hemorrhagic colitis associated with oral
administration of oseltamivir for the treatment of influenza
A infection.25
Our patient was previously healthy with no past history
of severe gastrointestinal disease. She had never undergone
any panendoscopy, so we are not able to determine defin-
itively whether she had a peptic ulcer upon admission.
However, the initial plain abdominal X-ray and abdominal
sonogram performed prior to administration of oseltamivir
did not reveal any sign of viscus perforation. Although the
exact time point at which perforation of the peptic ulcer
occurred could not be confirmed, it might be that this was
an adverse event related to the administration of oselta-
mivir as the patient was not administered any nonsteroidal
anti-inflammatory drugs or any other agents potentially
irritating to the gastrointestinal tract. However, it could
also be due to the influenza infection itself or the preceding
gastroenteritis.
Although acute bacterial appendicitis may occur at
any age, it occurs more frequently in young adults. The
incidence of acute appendicitis during influenza epi-
demics has increased. This could be a secondary effect of
immunosuppression by influenza infection or subsequent
bacterial infection after initial viral infection.26 The
appendicitis in our case was found incidentally during
operation for perforated hollow organ. The patient had
symptoms of fever, diffuse abdominal pain, and diarrhea
prior to operation, but no complaints of shifting
abdominal pain or localized pain over right lower quad-
rant region. Nevertheless, our case highlights the
requirement of pediatric healthcare workers to be aware
of the nonpulmonary complications of seasonal and
pandemic influenza as well as the potential adverse ef-
fects of oseltamivir administration during the influenza
season.
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